Lucid performed early-stage development work on Nevro’s first chronic pain device.

A neurostimulation company focused on developing therapeutic systems for obesity, hypertension and diabetes, asked Lucid for product development expertise…

A well-funded implantable technology development company focusing on solutions for hypertension and heart failure needed development of a proof of concept for a delivery tool for deployment of active implantable lead.

A leading Fortune 500 medical device technology company needed to develop functional prototypes for internal and external neuromodulation devices.